Cipla Limited: Berok Zindagi (unstoppable life)

Cipla, a pharmaceutical company, launched a campaign in India to drive social acceptance for inhalers in 10k patients, demonstrate an increase in preference for inhalers, engage 150k doctors and drive 150 organically driven and impactful stories.

Situation Analysis

Close to 93 million people in India suffer from chronic respiratory diseases, according to The Global Burden of Disease Report, and of this, around 37 million are asthmatics. India also accounts for over 42% of all global asthma deaths, making it the asthma capital of the world. In addition to adults, asthma is the most common chronic disorder among children in India as well. There is, therefore, an urgent need to increase awareness around the condition and the ways to effectively manage it. One of these ways is to use an inhaler. Despite the criticality of the situation,...

WARC subscribers can sign in to keep reading

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands